5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | NEUTRAL | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 26.00▼ | 26.00▼ | 26.00▼ | 27.13▼ | N/A |
MA10 | 26.06▼ | 26.15▼ | 26.43▼ | 25.18▲ | N/A |
MA20 | 26.19▼ | 26.88▼ | 26.35▼ | N/A | N/A |
MA50 | 26.60▼ | 28.04▼ | 26.04▼ | N/A | N/A |
MA100 | 28.49▼ | N/A | N/A | N/A | N/A |
MA200 | N/A | N/A | N/A | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.004▼ | -0.105▼ | -0.219▼ | N/A | N/A |
RSI | 35.760▼ | 41.023▼ | 44.429▼ | N/A | N/A |
STOCH | 46.667 | 22.532 | 15.122▼ | N/A | N/A |
WILL %R | -98.333▼ | -99.531▼ | -99.531▼ | N/A | N/A |
CCI | -128.197▼ | -81.396 | -82.037 | N/A | N/A |
Thursday, June 12, 2025 03:58 AM
BioNTech (NASDAQ:BNTX) has agreed to acquire its German rival CureVac (NASDAQ:CVAC) in an all-stock transaction worth nearly $1.25B, the companies announced Thursday. Shares of CureVac (NASDAQ:CVAC) ...
|
Thursday, June 12, 2025 03:29 AM
ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced updated data from the LOTIS-7 Phase 1b open-label ...
|
Thursday, June 05, 2025 04:54 AM
Disclosing new interim data from its Phase 1/2 AFFINITY DUCHENNE trial, Regenxbio (NASDAQ:RGNX) announced Thursday that its experimental gene therapy RGX-202 continued to benefit patients living with ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 27.00 | 27.00 | 25.36 | 25.36 | 22,350 |
12/06/25 | 25.79 | 29.00 | 25.79 | 26.70 | 27,030 |
11/06/25 | 26.45 | 27.40 | 24.75 | 25.56 | 23,080 |
10/06/25 | 32.00 | 35.21 | 27.945 | 27.945 | 41,338 |
09/06/25 | 26.20 | 30.365 | 23.2045 | 30.06 | 34,950 |
06/06/25 | 22.88 | 25.78 | 22.50 | 25.68 | 19,400 |
05/06/25 | 21.50 | 22.04 | 21.24 | 22.04 | 35,000 |
04/06/25 | 21.33 | 23.164 | 20.55 | 22.00 | 19,362 |
03/06/25 | 23.07 | 23.60 | 21.85 | 21.985 | 15,919 |
02/06/25 | 25.295 | 25.90 | 24.405 | 24.42 | 14,963 |
|
|
||||
|
|
||||
|
|